基本信息
浏览量:190
职业迁徙
个人简介
As Director of the Stanford MDS Center, Dr Greenberg has an active clinical practice focusing on myelodysplastic syndromes (MDS) and clonal myeloid disorders. His clinical research involves design and coordination of clinical trials using experimental drugs with biologic focus for both lower and higher risk MDS patients not responding to standard therapies. He is Coordinator of the International Working Group for Prognosis in MDS (IWG-PM) which generated the revised MDS classification system (the IPSS-R) and is now evaluating the impact of molecular mutations on this risk-based prognostic system. He is Chair of the NCCN Practice Guidelines Panel for MDS.
研究兴趣
论文共 268 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nivaz Brar, Lauren Lawrence,Eula Fung,James L Zehnder,Peter L Greenberg, Gabriel N Mannis,Tian Y Zhang,Dita Gratzinger,Jean Oak,Oscar Silva,Jason Kurzer,Brent Tan,
American journal of clinical pathology (2024)
LEUKEMIA RESEARCH (2024): 107433-107433
Blood (2024)
bioRxiv : the preprint server for biology (2024)
EXPERIMENTAL HEMATOLOGY (2023): S157-S157
BLOODno. Supplement 1 (2023): 997-997
Guillermo Garcia-Manero,Melissa Ooi,Zhentang Lao,Harinder Gill,Yasmin Abaza,Maximilian Stahl,Tamanna Haque,Amy E. DeZern,Peter L. Greenberg,Marc Pelletier, Arti Singh, Daniel Carreon,
BLOOD (2023): 3250
Cancer Researchno. 7_Supplement (2023): 6168-6168
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn